Page 3 of 4
Journal Name
RSC Advances
DOI: 10.1039/C5RA07770B
Scheme 1 Proposed Mechanism for the Tandem Reaction
(d) C. Hamdouchi, J. de Blas, M. del Prado, J. Gruber, B. A. Heinz,
L. Vance, J. Med. Chem.,1999, 42, 50; (e) M. H. Fisher, A. Lusi, J.
Med. Chem.,1972, 15, 982; (f) J. C. Teulade, G. Grassy, J. P. Girard,
J. P. Chapat, Eur. J. Med. Chem. 1978, 13, 271; (g) A. Gueiffier, S.
Mavel, M. Lhassani, A. Elhakmaoui, R. Snoeck, G. Andrei, O.
Chavignon, J. C. Teulade, M. Witvrouw, J. Balzarini, E. De Clercq, J.
P. Chapat, J. Med. Chem.,1998, 41, 5108; (h) C. Hamdouchi, J. de
Blas, M. del Prado, J. Gruber, B. A. Heinz, L. Vance, J. Med. Chem.
,
1999, 42, 50; (i) T. Scior, D. M. Domeyer, K. CuanaloContreras and
S. A. Laufer,Curr. Med. Chem., 2011, 18,1526; (j) T.ꢀT. Kong, C.ꢀM.
Zhang and Z.ꢀP. Liu, Curr. Med.Chem.,2013, 20, 1997.
3
(a) N. Singh and D. O. Jang, Org Lett., 2007,
9, 1991; (b) P.
Chaudhuri, B. Ganguly and S. Bhattacharya, J. Org. Chem., 2007, 72
,
Conclusions
1912; (c) A. Sannigrahi, D. Arunbabu, R.M. Sankar, T. Jana,
Macromolecules., 2007, 40, 2844; (d) Y. Ooyama, T. Nakamura, K.
Yoshida, New J. Chem. ,2005,29,447.
In summary, we have developed a new and mild strategy to
prepare functionalized imidazoles. This novel reaction can be
realized via a domino process involving a ringꢀopening of αꢀ
nitro epoxides and an intramolecular nucleophilic addition from
easily available αꢀnitroꢀepoxides and amidines or their analogues.
Operational simplicity, mild reaction conditions, and facile
substituent variation are all notable aspects of this methodology.
This makes it a highly practical approach in the medicinal chemistry.
4
(a) M. Salimi, M.A Nasseri, T.D Chapesshloo and B. Zakerinasab,
RSC Adv.,2015,
Adv.,2015, , 33177; (c) A.R. MoosaviꢀZare, Z. Asgari, A. Zare,
M.A. Zolfigol and M. Shekouhy RSC Adv.,2014, , 60636; (d) Z.
Zarnegar and J. Safari, RSC Adv.,2014, , 20932; (e) S. Balalaie and
5, 33974; (b)A. Maleki, and R Paydar, RSC
5
4
4
A. Arabanian,Green Chem., 2005,2, 274; (f) F. Bellina, S.
Cauteruccio and R. Rossi, Tetrahedron., 2007, 63, 4571; (g) M. Xia
and Y. Lu, J Mol. Catal. A-Chem., 2007, 265, 205; (h) J. Wang, R.
Mason, D. VanDerveer, K. Feng and X. R. Bu,J. Org. Chem., 2003,
68, 5415; (i) A. Shaabani and A. Rahmati, J MolCatal A-Chem.,
2006, 249, 246; (j) M. M. Heravi, K. Bakhtiari, H. A. Oskooie and S.
Taheri, J MolCatal A-Chem., 2007, 263, 279; (k) S. Das Sharma, P.
Hazarika and D. Konwar, Tetrahedron Lett., 2008, 49, 2216; (l)A.
Shaabani, A. Maleki and M. Behnam, Synth. Commun.,2009, 39,102.
(a) F. Shibahara, E. Yamaguchi and T. Murai, Chem. Commun., 2010,
46, 2471; (b)F. Shibahara, E. Yamaguchi and T. Murai, J. Org.
Chem., 2011, 76, 2680; (c) P. V. Kumar, W. Lin, J. Shen, D. Nandi
and H. M. Lee, Organometallics, 2011, 30, 5160; (d)A. Takfaoui, L.
Zhao, R. Touzani, J. Soulé, P. H. Dixneuf and H. Doucet,
Acknowledgment
This project was supported from the National Natural Science
Foundation of China (No. 81273356 and 81473074), National
Science & Technology Major Projects for “Major New Drugs
Innovation and Development” of China (2014ZX09304002ꢀ
007) , Program for Zhejiang Leading Team of S&T Innovation,
and Arthritis & Chronic Pain Research Institute, USA, to Y.Y.,
and the China Postdoctoral Science Foundation Funded Project
(2014M550331), National Natural Science Foundation of China
(No. 81402778) and the Fundamental Research Funds for the
Central Universities (No. 2015QNA7029) to W.C.
5
Tetrahedron
,
2014, 70
,
8316; (e)S. Bajpai, S. Singh and V.
,28163
Srivastava, RSC Adv., 2015,
5
6
J. F. Hayes, M.B. Mitchell, and C. Wicks, Heterocycles, 1994, 38,
575.
Notes and references
7
(a) R. L. Elliott, R. M. Oliver,J. A. LaFlamme, M. L. Gillaspy, M.
Hammond, R. F. Hank, T. S. Maurer, D. L. Baker, P. A. DaSilvaꢀ
Jardine, R. W. Stevenson, C. M. Mack and J. V. Cassella, Bioorg.
Med. Chem. Lett., 2003, 13, 3593; (b) D. Kumar, N. M. Kumar, G.
Patel, S. Gupta and R. S. Varma,Tetrahedron Lett., 2011, 52, 1983;
1
(a) J. Heeres, L. J. J. Backx, J. H. Mostmans, and J. Van Cutsem, J.
Med.Chem., 1979, 22, 1003; (b) R.W. Brimblecombe, W.A.M.
Duncan, G.J. Durant, J.C. Emmett, C. R. Ganellin, M. E. J. Parsons
Int. Med. Res., 1975,
3
, 86; (c) V. Gupta and V. Kant, Sci. Int., 2013,
, 167; (e) K. M.
1, 253; (d) J. R. Kumar, Pharmacophore., 2010,
1
(c) F. Bureš and J. Kulhánek, Tetrahedron: Asymmetry, 2005, 16
,
Dawood and B. F. AbdelꢀWahab, Chem. Heterocycl. Compd., 2010,
46, 255; (f) T. Imaoka, M. Iwata, T. Akimoto and K. Nagasawa, Nat.
1347; (d) T. J. Donohoe,M. A. Kabeshov, A. H. Rathi and I. E. D.
Smith, Org. Biomol. Chem., 2012, 10, 1093; (e) B. Li, C. K. F. Chiu,
R. F. Hank, J. Murry, J. Roth and H. Tobiassen, Org. Process Res.
Prod. Commun.,2013, 8, 961; (g) Z. Jin, Nat. Prod. Rep., 2013, 30,
869.
Dev., 2002, 6, 682;(f)T. Wiglenda and R. Gust, J. Med. Chem., 2007,
2
(a) G. Gudipudi, S.R. Sagurthi, S. Perugu, G Achaiah and G. L. D.
Krupadanam, RSC Adv., 2014, ,56489; (b) L. Wang, K. W. Woods,
50, 1475; (g) G. Ung and G. Bertrand, Chem-Eur J.,2011, 17, 8269.
(a) S. Mitra, A. K. Bagdi, A. Majee and A. Hajra, Tetrahedron Lett.,
4
8
Q. Li, K. J. Barr, R. W. McCroskey, S. M. Hannick, L. Gherke, R. B.
Credo, Y.ꢀH. Hui, K. Marsh, R. Warner, J. Y. Lee, N. Zielinskiꢀ
Mozng, D. Frost, S. H. Rosenberg, H. L. Sham, J. Med. Chem., 2002,
45, 1697; (c) M. A. Iradyan, N. S. Iradyan, G. M. Stepanyan, F. G.
Arsenyan and B. T. Garibdzhanyan, Pharm. Chem. J. ,2010, 44, 175;
2013, 54, 4982; (b) X. Liu, D. Wang and B. Chen, Tetrahedron
,
2013, 69, 9417; (c)T. Kumar, D. Verma, R. F. S. MennaꢀBarreto, W.
O. Valença, E. N. Da Silva Júnior and I. N. N. Namboothiri, Org.
Biomol. Chem., 2015, 13, 1996.
This journal is © The Royal Society of Chemistry 2012
J. Name., 2012, 00, 1-3 | 3